VALERIA PANEBIANCO

CORSO DI LAUREA "A" - DIAGNOSTICA PER IMMAGINI: 

- Orario Lezioni: https://corsidilaurea.uniroma1.it/it/corso/2020/30891/programmazione

- Link di accesso: https://corsidilaurea.uniroma1.it/it/node/2452830

CORSO DI LAUREA "F" - DIAGNOSTIC IMAGING:

Cari Studenti,

tutte le lezioni e le notizie relative alla didattica sono sempre condivise sulla piattaforma moodle dei vari moduli in cui insegno (https://elearning.uniroma1.it/).
Le lezioni, in questo periodo , sono svolte in modalità "blended" (in presenza e a distanza) in maniera sincrona utilizzando la piattaforma ZOOM o MEET a seconda delle modalità concordate nei vari Corsi di Laurea in cui insegno, seguendo il calendario delle lezioni fornito dal Corso di Laurea.

Dear students,

All lessons and news related to the teaching activities are always shared on the moodle platform of the various modules I teach in (https://elearning.uniroma1.it/).

The lessons, in this period, are carried out in blended mode (with students in the classroom and online) using the ZOOM or MEET platform according to the methods agreed on in the various Degree Courses. The lessons take place following the schedules of lessons provided by the Degree Courses.

CV

PERSONAL INFORMATION Valeria Panebianco

E-mail address: valeria.panebianco@uniroma1.it
CurrentPosition: Full Professor of Radiology (MEDS-22/A) - Director of Department of Radiological Sciences, Oncology and Pathology, Sapienza, Univ. of Rome

WORK EXPERIENCE

2024 – Present Director of the Department of Radiological Sciences, Oncology & Pathology Sapienza University of Rome
Sector: Academic and Health sector

2024 – Present Coordinator of the CARE Unit (Multidisciplinary Unit for the Application of Digital Medicine)
Sector: Academic and Health sector

2023 – Presen Full Professor of Radiology at the Department of Radiological Sciences, Oncology & Pathology Sapienza University of Rome
Sector: Academic and Health sector

09/2019–2023 Associate Professor of Radiology at Department of Radiological Sciences, Oncology & Pathology
Sapienza University of Rome, Rome (Italy)
Qualified to Full professor of Radiology – ASN 2016
Responsible, Advanced MR & CT Imaging Division at U.O.C. of Radiology (Dir. Prof. C. Catalano) Coordinator, Prostate Unit

2002–2019 Specialist Radiologist
Department of Radiology at Department of Radiological Sciences, Oncology & Pathology, Policlinico Umberto I, Rome (Italy)

1999–2002 Specialist Radiologist
Department of Emergency, Policlinico Umberto I, Rome (Italy)

EDUCATION AND TRAINING

2022 Good Clinical Practice Certificate The Global Health Network

2021-2022 Advanced Training Course in the Healthcare Management Sapienza University of Rome

2003–2007 Residency in Nuclear Medicine EQF level8
Sapienza University of Rome, Rome (Italy)

1998–2002 Volunteer Assistant
Department of Radiology at Department of Radiological Sciences, Oncology & Pathology, Policlinico Umberto I, Rome (Italy)
Reasearch in urogenital and abdominal CT scan - MRI

1994–1998 Residency in Diagnostic Imaging & Images Sciences
Sapienza Unviersity of Rome, Rome (Italy) EQF level 8

1988–1993 Degree in Medicine and Surgery
Sapienza University of Rome, Rome (Italy)
EQF level 7

Scientific Profile
Professor Panebianco has been a vital member of the several international scientific societies contributing significantly to the organization's guidelines and educational initiatives. She has served several times as a member of the scientific committee for the ECR and was involved as a subcommittee Chairperson for Genitourinary Radiology in 2024. Additionally, she has been a regular contributor to refresher courses at ECR and RSNA. She holds several prominent international roles, such as: Chairperson of the American College of Radiology VI-RADS Steering Committee, Member of the Communication and Interdisciplinary Affairs Committee of the ESR, Panel Member for the EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer, and Vice-Chair of the Prostate MRI Working Group of the ESUR. Professor Panebianco has authored more than 250 peer-reviewed papers, with a primary focus on prostate and bladder cancer imaging. Recently her research emphasized the application of computational medicine to identify biomarkers tumor early detection, personalized therapy and monitoring, through the development of Digital Twin technologies. She has led position papers on MRI standardization, specifically for bladder cancer (VI-RADS – Vesical Imaging Reporting and Data System) and prostate cancer recurrence (PI-RR – Prostate MRI for Local Recurrence Reporting). Additionally, Professor Panebianco was appointed by the World Health Organization to contribute to the WHO Blue Book on Urinary Tumors. She organized the first national screening trial for early prostate cancer detection, known as “Prostate Cancer Secondary Screening in Sapienza”. In 2022, VP participated to the PI-CAI Challenge on ArtificialIntelligence for Prostate Cancer Detection in MRI as member of the Scientific Advisory Board.

PERSONAL SKILLS

Mother tongue Italian,
Additional language English

ADDITIONAL INFORMATION

Appointments
Member of National PhD Course (2023-today): Faculty Member, PhD on Precision Medicine
Member of PhD Faculty (2021-2022): Faculty Member, PhD on Network Oncology and Precision Medicine
Board Member of the Residency programme in Radiology and Urology
International and national institutional appointments:
- 2024-Today: Vice-chair of the Prostate MRI working group of the European Society of Urogenital Radiology (ESUR)
- 2024-Today: Member of the Communication and Interdisciplinary Affairs Committee of the European Society of Radiology (ESR)
- 2024-Today: President of the Urogenital Radiology Section of the Italian Society of Radiology (SIRM)
- 2023-Today: Chairperson of the American College of Radiology (ACR) VI-RADS steering committee.
- 2023-Today: Member of the Technical-Management Committee of the “D3 4 Health” Project funded by the Piano Nazionale Complementare (PNC) to the National Recovery and Resilience Plan (NRRP – PNRR)
- 2023-Today: Member of the ISMRM - International Society of Magnetic Resonance in Medicine - Safety Committee
-2022-Today: Scientific Coordinator for Spoke 3 of the “D3 4 Health” Project funded by the Complementary National Plan (CNP - PNC) to the National Recovery and Resilience Plan (NRRP – PNRR)
- 2022-Today: Scientific Coordinator of WP 4 of Spoke 4 of the “HEAL ITALIA” Project fundend as “Partenariato Esteso 6” by the National Recovery and Resilience Plan (NRRP – PNRR)
- 2022-Today: Member of the Board of Directors (Consiglio di Amministrazione - CdA) of the “HEAL ITALIA” Project fundend as “Partenariato Esteso 6” by the National Recovery and Resilience Plan
- 2022-Today: Panel Member of the EAU guidelines on Muscle-Invasive and metastatic bladder cancer
- 2022-Today: Board Member of the EAU Section of Urological Imaging (ESUI)
- 2022-Today: Fellow of the ICIS - International Cancer Imaging Society
- 2020-Today: Member of the ESR Education Committee
- 2019-Today: ACR international representative, PI-RADS - Prostate Imaging Reporting and Data System- Committee of American College of Radiology /ACR)
- 2014/2020: Member, Genitourinary Scientific Sub-Committee of the ECR - European Congress of Radiology.)
- 2019-Today: Member, Committee of the STITCH - Sapienza information-based Technology InnovaTion Center for Health)
Director of international courses:
- 2022-2023: International Network Medicine Training Program in collaboration with Harvard School of Medicine
Organizer of national and international teaching classes & courses
- 2023: 29th ESUR Symposium, Director
- 2023: ECR 23 Chairperson of the GU Committee, member of the PPC (program planning committee)
- 2019: ESUR Prostate MRI 9th teaching course
- 2017-Today: Faculty Member and Promotor, EAU/ ESU - European School of Urology - MRI Masterclass in Prostate cancer)
Participation to the drafting of important projects for funding (i.e. PNC, PRIN, POS, HORIZON)
Editorial activity for many radiology and urology international journals as an expert.
Leadership skills: currently responsible for a > 10 people team

Scientific Activity
Author of:
- 261 printed papers on "peer-reviewed” journals
- 52 Books(Chapters)
- 5 Books(Monographs)
- H-Index: 48

Area of Research:
- Urogenital imaging focused on MRI of the prostate gland and the urinary bladder
- Computed Tomography, single-slice and multi-slice spiral CT (kidneys, virtoscopy); image post- processing.
- Digital twin technologies, integrated diagnostica and AI in radiology

Scientific Papers
Most relevant recent publications:

1. Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study.
Saha A, Bosma JS, Twilt JJ, van Ginneken B, Bjartell A, Padhani AR, Bonekamp D, Villeirs G, Salomon G, Giannarini G, Kalpathy-Cramer J, Barentsz J, Maier-Hein KH, Rusu M, Rouvière O, van den Bergh R, Panebianco V, Kasivisvanathan V, Obuchowski NA, Yakar D, Elschot M, Veltman J, Fütterer JJ, de Rooij M, Huisman H; PI-CAI consortium.
Lancet Oncol. 2024 Jul;25(7):879-887. doi: 10.1016/S1470-2045(24)00220-1

2. PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer.
Englman C, Maffei D, Allen C, Kirkham A, Albertsen P, Kasivisvanathan V, Baroni RH, Briganti A, De Visschere P, Dickinson L, Gómez Rivas J, Haider MA, Kesch C, Loeb S, Macura KJ, Margolis D, Mitra AM, Padhani AR, Panebianco V, Pinto PA, Ploussard G, Puech P, Purysko AS, Radtke JP, Rannikko A, Rastinehad A, Renard-Penna R, Sanguedolce F, Schimmöller L, Schoots IG, Shariat SF, Schieda N, Tempany CM, Turkbey B, Valerio M, Villers A, Walz J, Barrett T, Giganti F, Moore CM.
Eur Urol. 2024 Sep;86(3):240-255. doi: 10.1016/j.eururo.2024.03.014.

3. Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System.
Panebianco V, Briganti A, Boellaard TN, Catto J, Comperat E, Efstathiou J, van der Heijden AG, Giannarini G, Girometti R, Mertens L, Takeuchi M, Muglia VF, Narumi Y, Novara G, Pecoraro M, Roupret M, Sanguedolce F, Santini D, Shariat SF, Simone G, Vargas HA, Woo S, Barentsz J, Witjes JA.
Nat Rev Urol. 2024 Apr;21(4):243-251. doi: 10.1038/s41585-023-00830-2.

4. Prospective Validation Study of a Novel Integrated Pathway Based on Clinical Features, Magnetic Resonance Imaging Biomarkers, and MicroRNAs for Early Detection of Prostate Cancer
Pecoraro M, Catanzaro G, Conte F, Besharat ZM, Messina E, Laschena L, Trocchianesi S, Splendiani E, Sciarra A, Catalano C, Paci P, Ferretti E, Panebianco V
Eur Urol Oncol. 2023 Jun 1:S2588-9311(23)00108-6. doi: 10.1016/j.euo.2023.05.008

5. Low cancer yield in PI-RADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: is it time to reconsider scoring categorization?
Messina E., Pecoraro M., Laschena L., Bicchetti M., Proietti F., Ciardi A., Leonardo C., Sciarra A., Girometti R., Catalano C., Panebianco V.
European Radiology. 2023 Aug;33(8):5828-5839. doi: 10.1007/s00330-023-09605-0

6. Epidemiology of Renal Cell Carcinoma: 2022 Update
Bukavina L., Bensalah K., Bray F., Carlo M., Challacombe B., Karam J.A., Kassouf W., Mitchell T., Montironi R., O'Brien T., Panebianco V., Scelo G., Shuch B., van Poppel H., Blosser C.D., Psutka S.P.
European Urology. 2022; 82(5):529-542. doi: 10.1016/j.eururo.2022.08.019

7. Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score
Pecoraro M., Turkbey B., Purysko A.S., Girometti R., Giannarini G., Villeirs G., Roberto M., Catalano C., Padhani A.R., Barentsz J.O., Panebianco V.
Radiology. 2022; 304(2):342-350. doi: 10.1148/radiol.212252

8. Convolutional Neural Networks for Automated Classification of Prostate Multiparametric Magnetic Resonance Imaging Based on Image Quality
Cipollari S., Guarrasi V., Pecoraro M., Bicchetti M., Messina E., Farina L., Paci P., Catalano C., Panebianco V.
Journal of Magnetic Resonance Imaging. 2022; 55(2):480-490. doi: 10.1002/jmri.27879

9. ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging
Penzkofer T., Padhani A.R., Turkbey B., Haider M.A., Huisman H., Walz J., Salomon G., Schoots I.G., Richenberg J., Villeirs G., Panebianco V., Rouviere O., Logager V.B., Barentsz J.
European Radiology. 2021; 31(12):9567-9578. doi: 10.1007/s00330-021-08021-6

10. Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy
Panebianco V., Villeirs G., Weinreb J.C., Turkbey B.I., Margolis D.J., Richenberg J., Schoots I.G., Moore C.M., Futterer J., Macura K.J., Oto A., Bittencourt L.K., Haider M.A., Salomon G., Tempany C.M., Padhani A.R., Barentsz J.O.
European urology oncology. 2021; 4(6):868-876. doi: 10.1016/j.euo.2021.01.003

11. Focus on the Quality of Prostate Multiparametric Magnetic Resonance Imaging: Synopsis of the ESUR/ESUI Recommendations on Quality Assessment and Interpretation of Images and Radiologists’ Training
de Rooij M., Israël B., Barrett T., Giganti F., Padhani A.R., Panebianco V., Richenberg J., Salomon G., Schoots I.G., Villeirs G., Walz J., Barentsz J.O.
Eur Urol. 2020 Oct;78(4):483-485. doi: 10.1016/j.eururo.2020.06.023

12. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
Del Giudice F., Barchetti G., De Berardinis E., Pecoraro M., Salvo V., Simone G., Sciarra A., Leonardo C., Gallucci M., Catalano C., Catto J.W.F., Panebianco V.
Eur Urol. 2020 Jan;77(1):101-109. doi: 10.1016/j.eururo.2019.09.029

13. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
Del Giudice F., Leonardo C., Simone G., Pecoraro M., De Berardinis E., Cipollari S., Flammia S., Bicchetti M., Busetto G.M., Chung B.I., Gallucci M., Catalano C., Panebianco V.
BJU International. 2020; 126(5):610-619; doi: 10.1111/bju.15188

14. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)
Panebianco V., Narumi Y., Altun E., Bochner B.H., Efstathiou J.A., Hafeez S., Huddart R., Kennish S., Lerner S., Montironi R., Muglia V.F., Salomon G., Thomas S., Vargas H.A., Witjes J.A., Takeuchi M., Barentsz J., Catto J.W.F.
Eur Urol. 2018 Sep;74(3):294-306. doi: 10.1016/j.eururo.2018.04.029

15. Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?
Panebianco V., Barchetti G., Simone G., Del Monte M., Ciardi A., Grompone M.D., Campa R., Indino E.L., Barchetti F., Sciarra A., Leonardo C., Gallucci M., Catalano C.
Eur Urol. 2018 Jul;74(1):48-54. doi: 10.1016/j.eururo.2018.03.007

16. MRI-targeted or standard biopsy for prostate-cancer diagnosis
Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budäus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM; PRECISION Study Group Collaborators.
N Engl J Med. 2018 May 10;378(19):1767-1777. doi: 10.1056/NEJMoa1801993

Projects/grants
2011/ 2012. “MR for GU oncological pathologies”
Sponsor: Bayer Sharing Pharma
prot. n. 23-2010
Role: Principal Investigator
€10.000

2012/ 2013. “Neuroanatomical evaluation of periprostatic nerve before and after radical-prostatectomy using DTI Fiber Tracking and 3D fast- recovery fast spin-echo (FRFSE) cube overlapping at 3T" - Sponsor: General Electric (GE),
prot. n. CE 418/09
Role: Principal Investigator

2012/ 2013. “1H-MRS, MRP and DWI combined in the detection of prostate cancer foci in patient with biochemical alterations at 3T” Sponsor: General Electric (GE),
prot. n. CE 418/09
Role: Principal Investigator

2013. “Italian Molecular Imaging Network”- Iminet
Sponsor: MIUR (CNR funding).
Role: Appointed Radiologist for the AOU Policlinico Umberto I of Rome)
€61.429,00

2016. “Evaluation of diffusion weighted MRI in patients with resectable liver metastases from colorectal cancer treated with preoperative therapy”
EORTC, prot. n. 1423-IG-GITCG.
Role: Co-Investigator

2016/ 2019. “A Phase 3 Randomized, Placebo- controlled, Double-blind Study of JNJ- 56021927 Plus ADT Versus ADT in Subjects with Low-volume mHSPC - TITAN”.
Sponsor: Aragon Pharmaceuticals, Inc.
Prot. n. 56021927PCR3002; Phase 3 JNJ-56021927
Role: Co- investigator, responsible for imaging studies

2016/ 2018. “A randomised control trial of magnetic resonance imaging - targeted biopsy compared to standard trans-rectal ultrasound guided biopsy for the diagnosis of prostate cancer in men without prior biopsy (PRECISION)”
Role: National Coordinator and Principal investigator

2019. “A study of pattern of use for gadolinium-based contrast agents (GBCAs) in patients undergoing CE-MR examination - a cross- sectional, multicentre, observational study with prospective data collection” Sponsor: GE Healthcare Ltd. and its Affiliates; EU PAS: EUPAS21473
Role: Principal Investigator
€ 1.500,00

2020/ 2022. Computational Medicine for Prostate Cancer
University Research project, Sapienza - University of Rome Prot. RM120172A9138938
Role: Principal Investigator
€ 12.000,00

2020/ 2023. “REASONING: foRmal mEthods for computAtional analySis for diagnOsis and progNosis in imagING”
PRIN 2020 MUR – Prot. 2020YL3FB3
Role: Principal Investigator for Sapienza University
€ 178.469,00

2021/ 2024. “Health Technology Assessment of the Prostate Cancer Screening Randomized Controlled Trial (PROSA-I), combining Non- Contrast MRI and an Artificial Intelligence Algorithm”
University Research project, Sapienza - University of Rome Prot. RG12117A6795DBEE
Role: Principal Investigator of Sapienza University
ClinicalTrials.gov Identifier: NCT04803188
€ 45.000,00 + € 23.787,00

2022/ 2025. “A study assessing whether bi- parametric MRI is non-inferior to multi-parametric MRI in the diagnosis of clinically significant prostate cancer - (PRIME)” – Prot.
NCT04571840
Role: National Coordinator and Principal Investigator
€50
per participant
Total estimated number: 45

2022/ 2025. EUCAIM – “European Federation for Cancer Images”
Project ID - 101100633
Role: Co-Investigator
Total Budget of the project assigned to Sapienza
€ 291.494,75

2022. “A Multicentre, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients with Known or Suspected Focal Liver Lesions and Severe Renal
Impairment – SPARKLE - Sponsor: Ascelia Pharma Protocol ASC-Man-P016
Role: Co-Investigator

2022/ 2024. “A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ISIS 678354 Administered Subcutaneously to Patients with Severe Hypertriglyceridemia”
Sponsor: Ionis Pharmaceuticals, Inc. Protocol ISIS 678354-CS5
Role: Radiology co- Investigator for Sapienza University
-

2022/ 2025. “HEAL ITALIA” - Spoke 4: “4D
Precision Diagnostics - Precision medicine integrating clinical and imaging biomarkers for a precise in space and time diagnosis” NextGenerationEU - PNRR, Missione 4, componente 2 “Dalla Ricerca all'Impresa” - Partenariato Esteso 06
CUP: B53C22004000006
Role: Member of the Board of Directors & Scientific Coordinator of WP 4 of Spoke 4
Spoke 4 total:
€4.371.690,43
Total as WP4 Referent:
€ 292.676,00

2022/ 2026. “D3 4 Health: Digital Driven Diagnostics, prognostics and therapeutics for sustainable Health care”
Spoke 3: “Wearable technologies, sensors and biomarkers for care through Digital Twin approaches” Initiative of the “Piano Nazionale Complementari” (PNC) of the “PNRR” CUP: B53C22006120001
Role: Spoke 3 Scientific Coordinator
Total as Spoke 3 Coordinator
€9.721.688,37

2022/ 2026. “E-DAI”: Ecosistema digitale per analisi integrata di dati sanitari eterogenei relativi a patologie ad alto impatto: modello innovativo di assistenza e di ricerca.
Programme: Piano Operativo Salute (POS) 2014-2020 CUP: B83C22004150001
Role: Principal Investigator
Total
€3.400.000,00

2022/ 2025. “PRAISE-U - PRostate cancer Awareness and Initiative for Screening in the European Union” Europe Beating Cancer Plan - EU4Health (all.)
Role: Advisory Board Member for European Society of Radiology

2022. "In-Bore" MRI-Guided Targeted Biopsy for Prostate Cancer diagnosis: advanced equipment for a precise management” University Research project, Sapienza - University of Rome
Prot. MA32218168522B83
Role: Principal Investigator
€99.000,00

2022. “PANACEA - Prostate Cancer Screening and Early Detection based on Network Analysis of Digital Integrated Diagnostics” University Research project, Sapienza - University of Rome”
Prot. AH122183322E39F2
Role: Principal Investigator
€12.500,00

2024. "Integrated Diagnostics for Enhanced mAnagement of Bladder Cancer (IDEA-BC)"
Prot. RG124190E57F9C83
Role: Principal Investigator
€42.000,00

Conferences
Invited lectures
Participation as a lecturer to many events organised by international and national societies:
- 2021-2022-2023-2024: Several invited lectures in many national and international society congresses, courses and meetings.
- 2020: NIH (“A Tour Around VI-RADS”)
- 2016-Today: EAU
- 2014-Today: International Society of Magnetic Resonance in Medicine (ISMRM)
- 2014-Today: Radiological Society of North America (RSNA)
- 2010-Today: Italian Chapter dell’ International Society of MR in Medicine (ISMRM)
- 2009-Today: European Society of Urogenital radiology (ESUR)
- 1995-Today: European Society of Radiology (ESR) - European Congress of Radiology (ECR)
- 1994-Today: Società Italiana di Radiologia Medica (SIRM)

Oral Communications
Several communications from 1995 to 2014 during national and international congresses organized by the ISMRM, RSNA, ESUR, ECR and SIRM.

Society membership
2017-Today: European Society of Oncologic Imaging (ESOI) 2017-Today: International Cancer Imaging Society (ICIS)
2014-Today: International Society of Magnetic Resonance in Medicine (ISMRM) 2010-Today: Italian Chapter dell’ International Society of MR in Medicine (ISMRM) 2009-Today: European Society of Urogenital radiology (ESUR)
2000-Today: Radiological Society of North America (RSNA)
1995-Today: European Society of Radiology (ESR) - European Congress of Radiology (ECR) 1994-Today: Società Italiana di Radiologia Medica (SIRM)

Awards and Honors
2023: Honorary Membership of Sociedad Española de Diagnostico Por Imagen del Abdomen (SEDIA)
2021: SoME Award: Most influential article “Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus-based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical prostatectomy” published in European Urology Oncology, Volume 4, Issue 6, 2021, according to PlumX metrics.
2017: Honorary Membership of the Accademia Medica di Roma
2011: Award best presentation Members's day "3T DTI Fiber tracking in the depiction of perirprostatic nerve before and after nerve-sparing prostatectomy", 18th Annual Symposium ESUR
2009: Award best presentation Members's day "Comparison and correlation between1H-MRI in vivo prostate spectrosocpy at 1.5T and ex-vivo high resolution magic angle 1H-NMR Spectroscopy at 11T in the evaluation of new metabolite levels in prostate cancer", 16th European Symposium on Urogenital Radiology ESUR
2005: "Cum Laude" Award for the original research "Functional MRI of esophagus in healthy subjects: evaluation of normal patterns and future prospects" RSNA
2005: Best presentation Award on "Elaborazioni 3D", Convegno Nazionale della sezione di Radiologia Informatica, Verona 2005: